Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021
This Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Percutaneous Transluminal Coronary Angioplasty (PTCA) is a procedure that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. In this procedure, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The report enables you to -
Summary
This Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Percutaneous Transluminal Coronary Angioplasty (PTCA) is a procedure that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. In this procedure, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of PTCA Balloon Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
1.2 List of Figures
2 Introduction
2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters (PTCA) Overview
3 Products under Development
3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Segment
3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Territory
3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Regulatory Path
3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Estimated Approval Date
3.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Ongoing Clinical Trials
3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Segment
3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Territory
3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Regulatory Path
3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Estimated Approval Date
3.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Ongoing Clinical Trials
4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products under Development by Companies
4.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Stage of Development
5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Companies and Product Overview
5.1 3DT Holdings LLC Company Overview
5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aachen Resonance GmbH Company Overview
5.2.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced NanoTherapies Inc Company Overview
5.3.1 Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Andramed GmbH Company Overview
5.4.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Atrium Medical Corp Company Overview
5.5.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 B. Braun Interventional Systems Inc Company Overview
5.6.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biotronik AG Company Overview
5.7.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
5.8 Boston Scientific Corp Company Overview
5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Caliber Therapeutics Inc Company Overview
5.9.1 Caliber Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 CardioNiTi Ltd. Company Overview
5.10.1 CardioNiTi Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Chansu Vascular Technologies LLC Company Overview
5.11.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Concept Medical Inc Company Overview
5.12.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Cordis Corp Company Overview
5.13.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 CorNova Inc Company Overview
5.14.1 CorNova Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Cortis Life Sciences Company Overview
5.15.1 Cortis Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.16 Dingke Medical Technology (Suzhou) Co Ltd Company Overview
5.16.1 Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Innovia LLC Company Overview
5.17.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 iVascular SLU Company Overview
5.18.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview
5.19 Jiwei Medical System Ltd Company Overview
5.19.1 Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Lepu Medical Technology (Beijing) Co Ltd Company Overview
5.20.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 M.A. Med Alliance SA Company Overview
5.22.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
5.23 Medix Innovators Inc. Company Overview
5.23.1 Medix Innovators Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.24 Medtronic Plc Company Overview
5.24.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.25 MicroPort Scientific Corp Company Overview
5.25.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.26 Natec Medical Ltd Company Overview
5.26.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.27 OrbusNeich Company Overview
5.27.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.28 Orchestra BioMed Inc Company Overview
5.28.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 QT Vascular Ltd Company Overview
5.29.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.30 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.30.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.31 Rontis Hellas SA Company Overview
5.31.1 Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview
5.32 Sahajanand Laser Technology Ltd Company Overview
5.32.1 Sahajanand Laser Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Sahajanand Medical Technologies Pvt Ltd Company Overview
5.33.1 Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
5.34.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
5.35.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.36 SIS Medical AG Company Overview
5.36.1 SIS Medical AG Pipeline Products & Ongoing Clinical Trials Overview
5.37 Spectranetics Corp Company Overview
5.37.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.38 Terumo Aortic Company Overview
5.38.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
5.39 Transit Scientific LLC Company Overview
5.39.1 Transit Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
5.40 Vascular Nanotransfer Technologies Company Overview
5.40.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.41 Vascular Solutions LLC Company Overview
5.41.1 Vascular Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview
5.42 VasoTech Inc. Company Overview
5.42.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aachen Resonance GmbH Company Overview
5.2.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced NanoTherapies Inc Company Overview
5.3.1 Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Andramed GmbH Company Overview
5.4.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Atrium Medical Corp Company Overview
5.5.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 B. Braun Interventional Systems Inc Company Overview
5.6.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biotronik AG Company Overview
5.7.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
5.8 Boston Scientific Corp Company Overview
5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Caliber Therapeutics Inc Company Overview
5.9.1 Caliber Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 CardioNiTi Ltd. Company Overview
5.10.1 CardioNiTi Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Chansu Vascular Technologies LLC Company Overview
5.11.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Concept Medical Inc Company Overview
5.12.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Cordis Corp Company Overview
5.13.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 CorNova Inc Company Overview
5.14.1 CorNova Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Cortis Life Sciences Company Overview
5.15.1 Cortis Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.16 Dingke Medical Technology (Suzhou) Co Ltd Company Overview
5.16.1 Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Innovia LLC Company Overview
5.17.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 iVascular SLU Company Overview
5.18.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview
5.19 Jiwei Medical System Ltd Company Overview
5.19.1 Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Lepu Medical Technology (Beijing) Co Ltd Company Overview
5.20.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 M.A. Med Alliance SA Company Overview
5.22.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
5.23 Medix Innovators Inc. Company Overview
5.23.1 Medix Innovators Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.24 Medtronic Plc Company Overview
5.24.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.25 MicroPort Scientific Corp Company Overview
5.25.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.26 Natec Medical Ltd Company Overview
5.26.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.27 OrbusNeich Company Overview
5.27.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.28 Orchestra BioMed Inc Company Overview
5.28.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 QT Vascular Ltd Company Overview
5.29.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.30 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.30.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.31 Rontis Hellas SA Company Overview
5.31.1 Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview
5.32 Sahajanand Laser Technology Ltd Company Overview
5.32.1 Sahajanand Laser Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Sahajanand Medical Technologies Pvt Ltd Company Overview
5.33.1 Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
5.34.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
5.35.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.36 SIS Medical AG Company Overview
5.36.1 SIS Medical AG Pipeline Products & Ongoing Clinical Trials Overview
5.37 Spectranetics Corp Company Overview
5.37.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.38 Terumo Aortic Company Overview
5.38.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
5.39 Transit Scientific LLC Company Overview
5.39.1 Transit Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
5.40 Vascular Nanotransfer Technologies Company Overview
5.40.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.41 Vascular Solutions LLC Company Overview
5.41.1 Vascular Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview
5.42 VasoTech Inc. Company Overview
5.42.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters- Recent Developments
6.1 Sep 23, 2021: Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
6.2 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.3 Aug 13, 2021: QT Vascular Announces Condensed Interim Financial Statements for the six months ended 30 June 2021
6.4 Aug 10, 2021: Neovasc Announces Second Quarter 2021 Financial Results
6.5 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.6 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results
6.7 Jul 30, 2021: QT Vascular Announces Appointment of Independent Director
6.8 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.9 Jul 27, 2021: Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
6.10 Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
6.11 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.12 Jul 13, 2021: Neovasc Announces New Appointments in Regulatory and Clinical Leadership
6.13 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
6.14 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders
6.15 Jun 04, 2021: Getinge grows with social funding
6.16 Jun 03, 2021: Neovasc Reports Results of Annual General Meeting of Shareholders
6.17 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.18 May 20, 2021: Getinge Flow Family Anesthesia machines awarded contract with Vizient
6.19 May 06, 2021: Neovasc Announces First Quarter 2021 Financial Results
6.20 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.21 Apr 30, 2021: QT Vascular Announces Results of Annual General Meeting Held on 30 April 2021
6.22 Apr 15, 2021: Qt Vascular announces Annual General Meeting
6.23 Mar 26, 2021: Qt Vascular announce Financial Statements
6.24 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
6.25 Mar 11, 2021: Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
6.26 Mar 03, 2021: Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
6.27 Feb 18, 2021: Paclitaxel drug-coated balloons (DCBs) or drug-eluting stents (DESs): Reconfirmed position on use in patients with intermittent claudication and critical limb ischemia
6.28 Feb 17, 2021: Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference
6.29 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.30 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.31 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.32 Feb 09, 2021: Surmodics Reports First Quarter Fiscal 2021 Results
6.33 Feb 04, 2021: Terumo announce Financial Statements
6.34 Feb 01, 2021: Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9
6.35 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call on January 27, 2021
6.36 Jan 12, 2021: CardioFocus Invited to Participate in 23rd Annual ICR Conference and Needham Virtual Growth Conference
6.37 Jan 04, 2021: Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
6.38 Oct 27, 2020: Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4
6.39 Oct 22, 2020: Neovasc to Report Third Quarter Financial Results on November 5, 2020
6.2 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.3 Aug 13, 2021: QT Vascular Announces Condensed Interim Financial Statements for the six months ended 30 June 2021
6.4 Aug 10, 2021: Neovasc Announces Second Quarter 2021 Financial Results
6.5 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.6 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results
6.7 Jul 30, 2021: QT Vascular Announces Appointment of Independent Director
6.8 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.9 Jul 27, 2021: Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
6.10 Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
6.11 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.12 Jul 13, 2021: Neovasc Announces New Appointments in Regulatory and Clinical Leadership
6.13 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
6.14 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders
6.15 Jun 04, 2021: Getinge grows with social funding
6.16 Jun 03, 2021: Neovasc Reports Results of Annual General Meeting of Shareholders
6.17 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.18 May 20, 2021: Getinge Flow Family Anesthesia machines awarded contract with Vizient
6.19 May 06, 2021: Neovasc Announces First Quarter 2021 Financial Results
6.20 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.21 Apr 30, 2021: QT Vascular Announces Results of Annual General Meeting Held on 30 April 2021
6.22 Apr 15, 2021: Qt Vascular announces Annual General Meeting
6.23 Mar 26, 2021: Qt Vascular announce Financial Statements
6.24 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
6.25 Mar 11, 2021: Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
6.26 Mar 03, 2021: Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
6.27 Feb 18, 2021: Paclitaxel drug-coated balloons (DCBs) or drug-eluting stents (DESs): Reconfirmed position on use in patients with intermittent claudication and critical limb ischemia
6.28 Feb 17, 2021: Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference
6.29 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.30 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.31 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.32 Feb 09, 2021: Surmodics Reports First Quarter Fiscal 2021 Results
6.33 Feb 04, 2021: Terumo announce Financial Statements
6.34 Feb 01, 2021: Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9
6.35 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call on January 27, 2021
6.36 Jan 12, 2021: CardioFocus Invited to Participate in 23rd Annual ICR Conference and Needham Virtual Growth Conference
6.37 Jan 04, 2021: Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
6.38 Oct 27, 2020: Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4
6.39 Oct 22, 2020: Neovasc to Report Third Quarter Financial Results on November 5, 2020
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Stage of Development
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Segment
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Territory
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Regulatory Path
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Estimated Approval Date
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Ongoing Clinical Trials
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Companies - Pipeline Products by Stage of Development
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Stage of Development
- 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
- Conductance Balloon Coronary Post-Dilatation Catheter - Product Status
- Conductance Balloon Coronary Post-Dilatation Catheter - Product Description
- Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
- VIAR - Product Status
- VIAR - Product Description
- Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview
- Sirolimus Coated Angioplasty Balloon - Product Status
- Sirolimus Coated Angioplasty Balloon - Product Description
- Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Zero-Profile PTCA Balloon - Product Status
- Zero-Profile PTCA Balloon - Product Description
- Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
- Coronary Stent Balloon Catheter - Product Status
- Coronary Stent Balloon Catheter - Product Description
- B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- SeQuent Please - Product Status
- SeQuent Please - Product Description
- SeQuent Please ReX Drug Coated PTCA Balloon Catheter - Product Status
- SeQuent Please ReX Drug Coated PTCA Balloon Catheter - Product Description
- B. Braun Interventional Systems Inc - Ongoing Clinical Trials Overview
- SeQuent Please - A 2:1 Randomized Trial Comparing the Agent Paclitaxel-coated PTCA Balloon Catheter Versus SeQuent Please Drug Eluting Balloon Catheter for the Treatment of a Small Vessel De Novo Native Coronary Artery Lesion
- SeQuent Please - A Prospective, Randomized, Non-inferiority Trial to Determine the Safety and Efficacy of the BA9 Drug Coated Balloon for the Treatment of In-stent Restenosis: First-in-man Trial: REFORM
- SeQuent Please - A Randomized, Multicenter Study on the Efficacy and Safety of Paclitaxel-eluting PTCA-Balloon Catheter(SeQuent Please) Compared to POBA in the Treatment of Small Vessel Disease (SVD) Patient
- SeQuent Please - Bare Metal Stent Versus Drug Coated Balloon with Provisional Stenting in Non-ST-Elevation Myocardial Infarction
- SeQuent Please - Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined with Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: A Prospective, Randomized, Controlled Clinical Trial
- SeQuent Please - Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients with High Bleeding Risk: A Randomized, Single-center, Pilot Study
- SeQuent Please - Drug Eluting balloon for In-stent Restenosis. Multi-center, Randomized Trial to Study the Effect of the SeQuent Please Drug-eluting Balloon Versus the Xience Prime Drug-eluting Stent for the Treatment of In-stent Restenosis: DARE-Trial
- SeQuent Please - Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI
- SeQuent Please - Drug-coating Balloon Treatment in Coronary Artery Disease: A Prospective, Multicenter, Registry Study (ULTIMATE-DCB)
- SeQuent Please - Effect of Combination of Non-slip Element Balloon (NSE) and drug-coated balloon (DCB) for In-stent Restenosis Lesions (ELEGANT)
- SeQuent Please - Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis: a Randomized, Open-label, Positive Parallel Controlled, Multicenter Clinical Trial
- SeQuent Please - Prospective Randomised Study Comparing Efficacy of Treatment Coronary In-stent Restenosis Using Sirolimus-eluting and Iopromide-coated Paclitaxel-eluting Balloon Catheters
- SeQuent Please - Prospective Randomized Study Comparing Efficacy of Treatment Coronary In-stent Restenosis Using Drug Eluting Paclitaxel-coated Balloon and Drug Eluting Stent with Everolimus.
- SeQuent Please - Randomized Controlled Trial for Comparison of Efficacy and Safety Between Drug-eluting Balloon and 2nd Generation Drug-eluting Stent in Patients with In-scaffold Restenosis of Bioresorbable Vascular Scaffold
- SeQuent Please - To Evaluate the Long Term Safety and Efficacy of Drug Coated Balloon SeQuent Please in Chinese Coronary Instent Restenosis Patients, a Prospective, Multi-center, Randomization Clinical Trial
- SeQuent Please - Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter
- SeQuent Please ReX Drug Coated PTCA Balloon Catheter - A Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of Paclitaxel Balloon Dilator Versus Paclitaxel Releasing Coronary Balloon Catheter in the Treatment of in Stent Restenosis (ISR)
- SeQuent Please ReX Drug Coated PTCA Balloon Catheter - U.S. clinical trial of the SeQuent Please ReX Drug Coated PTCA Balloon Catheter
- Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
- Delivr - Product Status
- Delivr - Product Description
- Hatriq - Product Status
- Hatriq - Product Description
- Oscar - Product Status
- Oscar - Product Description
- Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- Agent Paclitaxel Coated-PTCA Balloon Catheter - Product Status
- Agent Paclitaxel Coated-PTCA Balloon Catheter - Product Description
- Boston Scientific Corp - Ongoing Clinical Trials Overview
- Agent Paclitaxel Coated-PTCA Balloon Catheter - A 2:1 Randomized Trial Comparing the Agent Paclitaxel-coated PTCA Balloon Catheter Versus SeQuent Please Drug Eluting Balloon Catheter for the Treatment of a Small Vessel De Novo Native Coronary Artery Lesion
- Agent Paclitaxel Coated-PTCA Balloon Catheter - AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects with In-Stent Restenosis (ISR)
- Caliber Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
- TADD Device - Product Status
- TADD Device - Product Description
- CardioNiTi Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- Scoring Balloon - Product Status
- Scoring Balloon - Product Description
- Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
- Coronary Everolimus Drug-Coated Balloon - Product Status
- Coronary Everolimus Drug-Coated Balloon - Product Description
- Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- MagicTouch PTCA Balloon Catheter - Product Status
- MagicTouch PTCA Balloon Catheter - Product Description
- Concept Medical Inc - Ongoing Clinical Trials Overview
- MagicTouch PTCA Balloon Catheter - An International, Multicenter, Spontaneous, Randomized Clinical trial of MagicTouch (Sirolimus Coated Balloon) Versus Everolimus Eluting Stent (EES) in Treating Small Coronary Vessel (Transform II)
- MagicTouch PTCA Balloon Catheter - Drug-Eluting Balloon Versus Drug-eluting Stent On de Novo coronary Artery Disease in Patients with High Bleeding Risk
- MagicTouch PTCA Balloon Catheter - Evaluate the Performance of a Sirolimus-Eluting Drug-Coated Balloon (SCB) For the Treatment of Any Coronary Lesions, Including De Novo Lesions and In-Stent Restenosis
- MagicTouch PTCA Balloon Catheter - Magic Touch Sirolimus Coated Balloon (Concept Medical) Versus SeQuent Please Neo Paclitaxel Coated Balloon (Bbraun) for the Treatment of de Novo Coronary Artery Lesions in Small Vessels
- MagicTouch PTCA Balloon Catheter - Performance of Sirolimus Coated Balloon Catheter System in Treatment of Lesions in Native Coronary Arteries
- MagicTouch PTCA Balloon Catheter - Prospective Randomised Study Comparing Efficacy of Treatment Coronary In-stent Restenosis Using Sirolimus-eluting and Iopromide-coated Paclitaxel-eluting Balloon Catheters
- MagicTouch PTCA Balloon Catheter - The All-comers Sirolimus-coated Balloon European Registry
- Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
- Next Generation EMPIRA PTCA Balloon - Product Status
- Next Generation EMPIRA PTCA Balloon - Product Description
- CorNova Inc Pipeline Products & Ongoing Clinical Trials Overview
- FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Status
- FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Description
- FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Status
- FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Description
- FiberHalo SRM Stent Delivery Catheter - Product Status
- FiberHalo SRM Stent Delivery Catheter - Product Description
- Cortis Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
- Core - PTCA - Product Status
- Core - PTCA - Product Description
- Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Dissolve - Product Status
- Dissolve - Product Description
- Dissolve AV - Product Status
- Dissolve AV - Product Description
- DK Score - Product Status
- DK Score - Product Description
- Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
- Low Profile Angioplasty Balloon Catheter - Product Status
- Low Profile Angioplasty Balloon Catheter - Product Description
- iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview
- Scoring Balloon - Product Status
- Scoring Balloon - Product Description
- Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Umimus Coated Coronary Artery Balloon Dilatation Catheter - Product Status
- Umimus Coated Coronary Artery Balloon Dilatation Catheter - Product Description
- Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Vesselin Drug Coated Coronary Balloon Catheter - Product Status
- Vesselin Drug Coated Coronary Balloon Catheter - Product Description
- Lepu Medical Technology (Beijing) Co Ltd - Ongoing Clinical Trials Overview
- Vesselin Drug Coated Coronary Balloon Catheter - Assess the Safety and Efficacy of Lepu Drug Coated Balloon Versus Restore Paclitaxel Eluting Balloon for the Treatment of Coronary Small-vessel Disease: a Prospective, Multicenter, Randomized, Controlled Trial
- Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- PTCA Drug Eluting Balloon - Product Status
- PTCA Drug Eluting Balloon - Product Description
- M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
- SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter - Product Status
- SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter - Product Description
- M.A. Med Alliance SA - Ongoing Clinical Trials Overview
- SELUTION SLR 014 Sirolimus Eluting PTCA Balloon Catheter - SELUTION Denovo - A Prospective Randomized, Multi-center, International, Single-blind, Clinical Trial Compared the Selution DEB Strategy Versus DES Strategy
- Medix Innovators Inc. Pipeline Products & Ongoing Clinical Trials Overview
- Hydra Bifurcated Coronary Balloon Catheter - Product Status
- Hydra Bifurcated Coronary Balloon Catheter - Product Description
- Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
- Euphora Drug Coated Balloon - Product Status
- Euphora Drug Coated Balloon - Product Description
- Prevail DCB Catheter - Product Status
- Prevail DCB Catheter - Product Description
- MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- Firefighter NC Pro Balloon Catheter - Product Status
- Firefighter NC Pro Balloon Catheter - Product Description
- Firefighter Pro Balloon Catheter - Product Status
- Firefighter Pro Balloon Catheter - Product Description
- Rapamycin Drug-Coated Balloon - Product Status
- Rapamycin Drug-Coated Balloon - Product Description
- Ryfle PTCA Balloon - Product Status
- Ryfle PTCA Balloon - Product Description
- Ryfle PTCA Balloon Catheter - Product Status
- Ryfle PTCA Balloon Catheter - Product Description
- Scoring Coronary Dilatation Catheter - Product Status
- Scoring Coronary Dilatation Catheter - Product Description
- Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- NATEC Angioplasty Balloon - Product Status
- NATEC Angioplasty Balloon - Product Description
- OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
- Coronary Scoreflex NC - Product Status
- Coronary Scoreflex NC - Product Description
- Limus Drug Coated Balloon - Coronary - Product Status
- Limus Drug Coated Balloon - Coronary - Product Description
- Next Generation PTCA Balloon - Product Status
- Next Generation PTCA Balloon - Product Description
- Sapphire Coronary Dilatation Catheter - 1.0mm Over-The-Wire - Product Status
- Sapphire Coronary Dilatation Catheter - 1.0mm Over-The-Wire - Product Description
- Sapphire III - Product Status
- Sapphire III - Product Description
- Sapphire NC 24 - Product Status
- Sapphire NC 24 - Product Description
- Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- Virtue Sirolimus-Eluting Balloon - ISR - Product Status
- Virtue Sirolimus-Eluting Balloon - ISR - Product Description
- Virtue Sirolimus-Eluting Balloon - Small Vessels - Product Status
- Virtue Sirolimus-Eluting Balloon - Small Vessels - Product Description
- QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Status
- Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Description
- Silk PTCA Balloon Catheter - Product Status
- Silk PTCA Balloon Catheter - Product Description
- QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
- Biodegradable Balloon - Product Status
- Biodegradable Balloon - Product Description
- Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview
- Rontis Drug Coated Balloon - Product Status
- Rontis Drug Coated Balloon - Product Description
- Rontis Hellas SA - Ongoing Clinical Trials Overview
- Rontis Drug Coated Balloon - A Prospective, Multicenter, Single-arm, Pre CE-marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries
- Sahajanand Laser Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Ripper - PTCA Balloon Catheter - Product Status
- Ripper - PTCA Balloon Catheter - Product Description
- Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Advanced Balloon Catheter - Product Status
- Advanced Balloon Catheter - Product Description
- Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Bioheart Impulse Balloon Dilatation Catheter - Coronary Artery Calcification - Product Status
- Bioheart Impulse Balloon Dilatation Catheter - Coronary Artery Calcification - Product Description
- Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Rapamycin Drug-Loaded Coronary ISR Balloon - Product Status
- Rapamycin Drug-Loaded Coronary ISR Balloon - Product Description
- Rapamycin Drug-Loaded Coronary LV Balloon - Product Status
- Rapamycin Drug-Loaded Coronary LV Balloon - Product Description
- SIS Medical AG Pipeline Products & Ongoing Clinical Trials Overview
- BEO NC - Product Status
- BEO NC - Product Description
- EasyT PTCA Dilatation Catheter - Product Status
- EasyT PTCA Dilatation Catheter - Product Description
- NIC 1.1 Hydro CTO PTCA Dilatation Catheter - Product Status
- NIC 1.1 Hydro CTO PTCA Dilatation Catheter - Product Description
- NIC 1.1 x 12 - Product Status
- NIC 1.1 x 12 - Product Description
- NIC Nano 0.85 ULP CTO - Product Status
- NIC Nano 0.85 ULP CTO - Product Description
- NIC Nano Hydro CTO Balloon - Product Status
- NIC Nano Hydro CTO Balloon - Product Description
- OPN NC Super High Pressure PTCA Balloon - Product Status
- OPN NC Super High Pressure PTCA Balloon - Product Description
- TIN - Product Status
- TIN - Product Description
- SIS Medical AG - Ongoing Clinical Trials Overview
- OPN NC Super High Pressure PTCA Balloon - Optimal Lesion Preparation with Non-compliant Balloons for the Implantation of Bioresorbable Vascular Scaffolds (BVS): OPRENBIS Study
- Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
- CardioSculpt Valvuloplasty Scoring Balloon - Product Status
- CardioSculpt Valvuloplasty Scoring Balloon - Product Description
- Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status
- Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description
- Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
- Flash PTCA - Product Status
- Flash PTCA - Product Description
- Runner PTCA Balloon Catheter - Product Status
- Runner PTCA Balloon Catheter - Product Description
- Runner Slim PTCA - Product Status
- Runner Slim PTCA - Product Description
- Transit Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
- XO Score - Rapid Exchange - Product Status
- XO Score - Rapid Exchange - Product Description
- Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
- Mitomycin-Based DCB - Coronary - Product Status
- Mitomycin-Based DCB - Coronary - Product Description
- Paclitaxel-Based Drug Coated Balloon - Coronary - Product Status
- Paclitaxel-Based Drug Coated Balloon - Coronary - Product Description
- Vascular Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview
- Ringer Perfusion Balloon Catheter - Product Status
- Ringer Perfusion Balloon Catheter - Product Description
- Vascular Solutions LLC - Ongoing Clinical Trials Overview
- Ringer Perfusion Balloon Catheter - A Prospective, Multicenter, Single-arm Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA Study)
- Ringer Perfusion Balloon Catheter - A Prospective, Multicenter, Single-arm Investigation of the Ringer Perfusion Balloon Catheter Performed Under an Exception From Informed Consent (EFIC) (Ringer IDE Study)
- VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
- DirectBalloon - Product Status
- DirectBalloon - Product Description
- Glossary
List of Figures
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Stage of Development
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Segment
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Territory
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Regulatory Path
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Pipeline Products by Estimated Approval Date
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3DT Holdings LLC
- Aachen Resonance GmbH
- Advanced NanoTherapies Inc
- Andramed GmbH
- Atrium Medical Corp
- B. Braun Interventional Systems Inc
- Biotronik AG
- Boston Scientific Corp
- Caliber Therapeutics Inc
- CardioNiTi Ltd.
- Chansu Vascular Technologies LLC
- Concept Medical Inc
- Cordis Corp
- CorNova Inc
- Cortis Life Sciences
- Dingke Medical Technology (Suzhou) Co Ltd
- Innovia LLC
- iVascular SLU
- Jiwei Medical System Ltd
- Lepu Medical Technology (Beijing) Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- M.A. Med Alliance SA
- Medix Innovators Inc.
- Medtronic Plc
- MicroPort Scientific Corp
- Natec Medical Ltd
- OrbusNeich
- Orchestra BioMed Inc
- QT Vascular Ltd
- QualiMed Innovative Medizinprodukte GmbH
- Rontis Hellas SA
- Sahajanand Laser Technology Ltd
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Shenzhen Salubris Pharmaceuticals Co Ltd
- SIS Medical AG
- Spectranetics Corp
- Terumo Aortic
- Transit Scientific LLC
- Vascular Nanotransfer Technologies
- Vascular Solutions LLC
- VasoTech Inc.